Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Politics

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

admin by admin
March 4, 2025
in Politics
0
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings growth potential.

According to Investor’s Business Daily, several under-the-radar companies are expected to post explosive earnings gains in the coming year, making them attractive picks for those seeking substantial portfolio growth.

Following are five such stocks that could supercharge your portfolios:

Privia Health (PRVA) set for triple-digit growth

Privia Health (PRVA), a provider of medical technology solutions, is set to see its earnings per share soar by 125% in the next year, with a further 42% increase expected the following year, according to FactSet.

The company reassured investors with its 2025 outlook despite challenges in the Medicare Advantage market.

Privia Health stock has surged about 28% in 2025, significantly outperforming the broader US market, which is down by approximately 1%.

Corcept Therapeutics (CORT) rides biotech wave

Corcept Therapeutics (CORT), a biotech firm focused on cortisol-modulating drugs, is another standout.

Analysts project earnings per share will rise 55% in 2025 and another 86% in 2026.

Sales are expected to jump by 34% and 30% over the next two years, respectively.

Despite missing Q4 estimates, Corcept provided an upbeat 2025 forecast on Feb. 26.

The stock has climbed nearly 20% year to date.

TG Therapeutics (TGTX) delivers a stunning turnaround

TG Therapeutics (TGTX) has emerged as a major player in the multiple sclerosis treatment market with its flagship drug Briumvi.

The company, which recently turned profitable, is forecast to see a staggering 570% surge in earnings per share in 2025, driven by a projected 70% increase in sales.

Following a strong Q4 earnings report, shares surged 17% on Monday. Year to date, TGTX stock has gained 16.5%.

TKO Group (TKO) flexes entertainment dominance

TKO Group (TKO), the owner of Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE), is poised for a dramatic earnings surge.

Analysts expect per-share earnings to jump to $3.04 in 2025 from just two cents in 2024, followed by another 73% increase in 2026. Sales are projected to grow 15.5% next year.

The company posted a strong Q4 report, swinging to a profit for 2024, and TKO stock is up 4% year to date.

Gilead Sciences (GILD) rebounds with strong forecast

Gilead Sciences (GILD), a leading biopharmaceutical company, is on track to reverse three consecutive years of earnings decline.

Fuelled by strong sales of its HIV treatment Biktarvy and its Covid therapy Veklury, Gilead is projected to see a 72% rise in earnings per share in 2025, with an additional 5.5% increase in 2026.

The stock has risen 25% year to date.

The post Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 appeared first on Invezz

Previous Post

From cheese to wine: Italian farmers lobby urges EU to fight back against Trump’s tariffs

Next Post

iDEGEN goes live on BitMart today: here’s why it matters

admin

admin

Next Post
iDEGEN goes live on BitMart today: here’s why it matters

iDEGEN goes live on BitMart today: here’s why it matters

Trending News

Long BYRN: Byrna Technologies Surges Past Previous Highs Following Record Q4 Earnings

Long BYRN: Byrna Technologies Surges Past Previous Highs Following Record Q4 Earnings

February 11, 2025
ASML CEO says AI boom benefits the company

ASML CEO says AI boom benefits the company

November 14, 2024
C3.ai to see ‘exceptional rapid growth’ in federal business under Musk-led Doge

C3.ai to see ‘exceptional rapid growth’ in federal business under Musk-led Doge

December 10, 2024
Subscribe to Insightful Word


    Recent News

    Consolidation in the markets

    Consolidation in the markets

    June 1, 2025
    Adobe stock price is cheap: is it a good buy?

    Adobe stock price is cheap: is it a good buy?

    June 1, 2025
    UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

    UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

    June 1, 2025
    LATAM crypto news: Interpol targets leader of Daily Cop scam, Guatemala advances on crypto regulation

    LATAM crypto news: Interpol targets leader of Daily Cop scam, Guatemala advances on crypto regulation

    June 1, 2025

    Recent News

    Consolidation in the markets

    Consolidation in the markets

    June 1, 2025
    Adobe stock price is cheap: is it a good buy?

    Adobe stock price is cheap: is it a good buy?

    June 1, 2025

    Latest News

    • Consolidation in the markets
    • Adobe stock price is cheap: is it a good buy?
    • UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.